The Lancet: Trial confirms Ebola vaccine candidate safe and equally immunogenic in Africa
This item is under embargo and is only visible to journalists
Please login here
Regions: Africa, Sierra Leone, Uganda, Guinea, Liberia, North America, United States, Europe, United Kingdom
Keywords: Health, Medical
The item has been withdrawn. If you are a journalists please contact the person that posted the item with any questions.